Skip to main content
Mijn bibliotheek
Ga naar:
Nieuws Boeken Tijdschriften Toetsvragen Web-tv Video Audio
Tips voor Mijn BSL
BSL Shop
Inloggen

Welkom bij Erasmus MC & Bohn Stafleu van Loghum

Erasmus MC heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen. Je kunt je links eenvoudig registreren. Met deze gegevens kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL.

» Andere revante producten voor Erasmus MC studenten en medewerkers.

Registreer

Om ook buiten de locaties van Erasmus MC, thuis bijvoorbeeld, van Mijn BSL gebruik te kunnen maken, moet je jezelf eenmalig registreren. Dit kan alleen vanaf een computer op een van de locaties van Erasmus MC.

Eenmaal geregistreerd kun je thuis of waar ook ter wereld onbeperkt toegang krijgen tot Mijn BSL.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Inloggen
Top
Gepubliceerd in:
hoofdstuk lezen eerste hoofdstuk lezen

2011 | OriginalPaper | Hoofdstuk

2. Genderverschillen bij Coronaire Hartziekten

Auteurs : Dr. Aagela Maas, Prof. Dr. Toine Lagro-Janssen

Gepubliceerd in: Handboek gynaecardiologie

Uitgeverij: Bohn Stafleu van Loghum

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

De afgelopen decennia is de acute sterfte aan cardiovasculaire ziekten (CVZ) meer gedaald bij mannen dan bij vrouwen. Door de toename in prevalentie van CVZ in de bevolking is er een verschuiving opgetreden naar een groter aantal chronische patiënten met cardiovasculaire aandoeningen. De jaarlijkse sterfte aan CVZ in Nederland is momenteel hoger bij vrouwen dan bij mannen.1 Omdat zij gemiddeld ouder worden heeft dit een grote impact op de kwaliteit van leven bij vrouwen op hoge leeftijd. Hoewel zij minder vaak een acuut myocardinfarct krijgen, worden vrouwen vaker getroffen door een ischemisch CVA dan mannen (figuur 2.1 en 2.2).2
vorige hoofdstuk Gender, Communicatie en Coping Bij Klachten Van Het Hart
volgende hoofdstuk Differentiële Diagnostiek bij Klachten van Pijn op de Borst en Dyspnoe bij Vrouwen
Literatuur
1.
2.
3.
Endres M, Heuschmann PU, Laufs U, Hakim AM. Primary prevention of stroke: blood pressure, lipids and heart failure. Eur Heart J 2011; 32: 545–52.PubMedCrossRef
4.
Dallongevillle J, De Bacquer D, Heidrich J, De Backer G, Prugger C, Kotseva K, Montaye M, Amouyel P; EUROASPIRE Study Group. Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event. Heart 2010; 96: 1744–49.PubMedCrossRef
5.
Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006; 332:73–78.PubMedCrossRef
6.
Lloyd-Jones DM, Leip EP, Larson MG, D’Agostino RB, Beiser A, Wilson PWF, et al. Predicion of life-time risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 2006; 113: 791–98.PubMedCrossRef
7.
Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women. The Reynolds Risk Score. JAMA 2007; 297: 611-19.PubMedCrossRef
8.
Shaw LJ, Bugiardini R, Bairey Merz CN. Women and ischemic heart disease. Evolving knowledge. J Am Coll Cardiol 2009; 54: 1561–75.PubMedCrossRef
9.
Vaccarino V, Badimon L, Corti R, Wit C de, Dorobantu M, Hall A, et al. Ischaemic heart disease in women: are there sex differences in pathofysiology and risk factors? Cardiovasc Res 2011; 90: 9–17.PubMedCrossRef
10.
Maas AHEM, Schouw YT van der, Regitz-Zagrosek V, Swahn E, Appelman YE, Pasterkamp G, et al. Red alert for women’s heart: the urgent need for more research and knowledge on cardiovascular disease in women. Eur Heart J 2011; 32: 1362–68PubMedCrossRef
11.
Raggi P, Gongora MC, Gopal A, Callister TQ, Budoff M, Shaw LJ. Coronary artery calcium to predict all-cause mortality in elderly men and women. J Am Coll Cardiol 2008; 52: 17–23.PubMedCrossRef
12.
Shaw LJ, Min JK, Narula J, Lin F, Bairey-Merz CN, Callister TQ, Berman DS. Sex differences in mortality associated with computed tomographic angiographic measurements of obstructive and non-obstructive coronary artery disease. An exploratory analysis. Circ Cardiovasc Imaging 2010; 3: 473–81.PubMedCrossRef
13.
Prescott E, Hippe M, Schnohr P, Hein HO, Vestbo J. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 1998; 316: 1043–47.PubMedCrossRef
14.
Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation 2011; 123: e18-e209.PubMedCrossRef
15.
Vasan RS, Larson MG, Leip EP, Evans JC, O’Donnell CJ, Kannel WB, Levy D. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: 1291–97.PubMedCrossRef
16.
Abbey M, Owen A, Suzakawa M, Roach P, Nestel PJ. Effects of menopause and hormone replacement therapy on plasma lipids, lipoproteins and LDL-receptor activity. Maturitas 1999; 33: 259–69.PubMedCrossRef
17.
Regitz-Zagrosek V, Lehmkuhl E, Mahmoodzadeh S. Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease. Gend Med 2007; 4 (suppl): S162-77.PubMedCrossRef
18.
De Simone G, Devereux RB, Chinali M, Lee ET, Galloway JM, Barac A, Panza JA, Howard BV. Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study. J Hypertens 2010; 28: 353–60.PubMedCrossRef
19.
Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340: 1801-11.PubMedCrossRef
20.
Bairey Merz CN, Johnson BD, Sharaf BL et al. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol 2003; 41: 413-19.PubMedCrossRef
21.
Shaw LJ, Bairey Merz CN, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health-NHLBI sponsored Women’s Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 2008; 93: 1276–84.PubMedCrossRef
22.
Ossewaarde ME, Bots ML, Verbeek AL, Peeters PH, Graaf Y van der, Grobbee DE, Schouw YT van der. Age at menopause, cause-specific mortality and total life expectancy. Epidemiology 2005; 16: 556–62.PubMedCrossRef
23.
Bellamy L, Casas JP, Hingorani AD, Williams DJ. Preeclampsia and risk of cardiovascular disease and cancer later in life: systematic review and meta-analysis. BMJ 2007; 335: 974–83.PubMedCrossRef
24.
25.
Magnussen EB, Vatten LJ, Smith GD, Romundstad PR. Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstet Gynaecol 2009; 114: 961–70.CrossRef
26.
Retnakaran R, Ying Q, Zinman B, Sermer M, Hanley A, Conelly P. Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women. J Clin Endocrinol Metab 2010;95: 670–77.PubMedCrossRef
27.
Drost JT, Maas AH, Eyck J van, Schouw YT van der. Preeclampsia as a female-specific risk factor for chronic hypertension. Maturitas 2010; 67: 321–26.PubMedCrossRef
28.
Low CA, Thurston RC, Matthews KA. Psychosocial factors in the development of heart disease in women: Current Research and Future Directions. Psychosom Med 2010; 72: 842–54.PubMedCrossRef
29.
Robertson N, Javed N, Samani NJ, Khunti K. Psychological morbidity and illness appraisals of patients with cardiac and non-cardiac chest pain attending a rapid access chest pain clinic: a longitudinal cohort study. Heart 2008; 94: e12.PubMedCrossRef
30.
31.
Orth-Gomér K, Schneiderman N, Wang HX, Walldin C, Blom M, Jernberg T. Stress reduction prolongs life in women with coronary disease. The Stockholm women’s intervention trial for coronary heart disease (switchd). Circ Cardiovasc Qual Outcomes 2009; 2: 25–32.PubMedCrossRef
32.
Daly CA, Clemens F, Sendon JLL, Tavazzi L, Boersma E, Danchin N, et al. Gender differences in the management and clinical outcome in stable angina. Circulation 2006; 113: 490–98.PubMedCrossRef
33.
Wenger NK, Shaw LJ, Vaccarino V. Coronary heart disease in women: update 2008. Clinical Pharmacol&Therapeutics 2008; 83: 37–51.CrossRef
34.
Hemingway H, Langenberg C, Damant J, Frost C, Pyörälä K, Barrett-Connor E. Prevalence of angina in women versus men. A systematic review and meta-analysis of international variations across 31 countries. Circulation 2008; 117: 1526–36.PubMedCrossRef
35.
Tamis-Holland JE, Lu J, Bittner V, Magee MF,Lopes N, Dale S. Adler DS, et al. Sex, clinical symptoms, and angiographic findings in patients with diabetes mellitus and coronary artery disease (from the Bypass Angioplasty Revascularization Investigation [bari] 2 Diabetes Trial). Am J Cardiol 2011; 107: 980–85.PubMedCrossRef
36.
Pepine CJ, Balaban RS, Bonow RO, Diamond GA, Johnson BD, Johnson PA, et al. Women’s ischemic syndrome evaluation. Diagnosis of stable ischemia and ischemic heart disease. Circulation 2004; 109: e44-e46.PubMedCrossRef
37.
Wall E van der, Werf F van de, Zijlstra F, red. Cardiologie; 2e dr. Houten: Bohn Stafleu van Loghum, 2008.
38.
Donoghue MO, Boden W, Braunwald E, Cannon CP, Clayton TC, Winter RJ de, et al. Early invasive versus conservative treatment strategies in women and men with unstable angina and non-ST myocardial infarction. JAMA 2008; 300: 71–80.CrossRef
39.
Hochman JS, Tamis JE, Thompson TD, Weaver WD, White HD, Werf F van de, et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. N Engl J Med 1999; 341: 226-32.PubMedCrossRef
40.
Diercks DB,Owen KP, Kontos MC, Blomkalns A, Chen AY, Miller C, Wiviott S, Peterson ED. Gender differences in time to presentation for myocardial infarction before and after a nationalwomen’s cardiovascular awareness campaign: a temporal analysis from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation (CRUSADE) and the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get with the Guidelines (NCDR ACTION Registry-GWTG). Am Heart J 2010; 160: 80–87.PubMedCrossRef
41.
Parashar S, Reid KJ, Spertus JA, Shaw LJ, Vaccarino V. Early menopause predicts angina after myocardial infarction. Menopause 2010; 17: 938–45.PubMedCrossRef
42.
Kannel WB, Feinleib M: Natural history of angina pectoris in the Framingham study. Prognosis and survival. Am J Cardiol 1972; 29: 154–63.PubMedCrossRef
43.
McSweeney JC, Cody M, O’Sullivan P, Elberson K, Moser DK, Garvin BJ. Women’s early warning symptoms of acute myocardial infarction. Circulation 2003; 108: 2619–23.PubMedCrossRef
44.
Lee TH, Rouan GW, Weisberg MC, et al. Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the ER. Am J Cardiol 1987; 60: 219-24.PubMedCrossRef
45.
Pope JH, Aufderheide TP, Ruthazer R, Woolard RH, Feldman JA, Beshansky JR, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 2000; 342: 1163-70.PubMedCrossRef
46.
Maas AH, Boer MJ de. Interpretatie klachten van pijn op de borst bij vrouwen. Hartbulletin 2010;41:44-46
47.
Canto JG, Goldberg RJ, Hand MM, Bonow RO, Sopko G, Pepine CJ, Long T. Symptom presentation of women with acute coronary syndromes: myth vs reality. Arch Intern Med 2007; 167:2405-13.PubMedCrossRef
48.
Milner KA, Funk M, Richards S, et al. Gender and age differences in chief complaints of acute myocardial infarction (Worcester Heart Attack Study). Am J Cardiol 2004;93:606–8.PubMedCrossRef
49.
Jongman JK, van Tol CA, Nienhuis MB, Debrauwere J, San WJ, Elvan A. Takotsubo cardiomyopathy; reversible cardiomyopathy induced by stress. Ned Tijdschr Geneeskd 2009; 153: B363.PubMed
50.
Previtali M, Repetto A, Camporotondo R, Citro R, Faggiano P, Bovelli D, et al. Clinical characteristics and outcome of left ventricular ballooning syndrome in a European population. Am J Cardiol 2011; 107: 120-25.PubMedCrossRef
51.
Bugiardini R, Bairey Merz CN. Angina with ‘normal’ coronary arteries: a changing philosophy. JAMA 2005; 293: 477–84.PubMedCrossRef
52.
53.
Melikian N, De Bruyne B, Fearon WF, MacCarthy PA. The pathophysiology and clinical course of the normal coronary angina syndrome. Progr Cardiovasc Dis 2008; 50: 294–310.CrossRef
54.
Lanza GA, Crea F. Primary coronary microvascular dysfunction. Clinical presentation, pathophysiology, and management. Circulation 2010; 121: 2317-25.PubMedCrossRef
55.
Banks K, Puttagunta D, Murphy S, Lo M, McGuire DK, de Lemos JA et al. Clinical characteristics, vascular function and inflammation in women with angina in the abscence of coronary atherosclerosis. J Am Coll Cardiol Img 2011; 4: 65–73.
56.
Phan A, Shufelt C, Bairey Merz CN. Persistent chest pain and no obstructive coronary artery disease. JAMA 2009; 301: 1468–74.PubMedCrossRef
57.
Doyle M, Weinberg N, Pohost GM, Bairey Merz CN, Shaw LJ, Sopko G, et al. Prognostic value of global mr myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease. Results from the NHBL-sponsored wise (Women’s Ischemic Syndrome Evaluation) Study. J Am Coll Cardiol Img 2010; 3: 1030–36.
58.
Mieres JH, Shaw LJ, Arai A, Budoff MJ, Flamm SD, Hundley WG, et al. Role of non-invasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement. Circulation 2005: 111: 682–96.PubMedCrossRef
59.
Shaw LJ, Bairey Merz CN, Pepine CJ, Reis SE, Bittner V, Kelsey SF, et al. Insights from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study. Part 1: gender differences in traditional and novel risk factors, symptom evaluation and gender-optimized diagnostic strategies. J Am Coll Cardiol 2006; 47: 4S-20S.CrossRef
60.
Kohli P, Gulati M. Exercise testing in women. Going back to the basics. Circulation 2010; 122: 2570–80.PubMedCrossRef
61.
Rautaharju PM, Kooperberg C, Larson JC, LaCroix A. Electrocardiographic abnormalities that predict coronary heart disease events and mortality in postmenopausal women. The Women’s Health Initiative. Circulation 2006; 113: 473–80.PubMedCrossRef
62.
Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronaryartery disease. N Engl J Med 1979; 300: 1350–58.PubMedCrossRef
63.
Genders TSS, Steyerberg EW, Alkadhi H, Leschka S, Desbiolles L, Nieman K, et al. A clinical prediction rule for the diagnosis of coronary artery disease: validation, updating, and extension. Eur Heart J 2011; 32: 1316–30.PubMedCrossRef
64.
Maas AHEM, Appelman YEA. Gender differences in coronary heart disease. Neth Heart J 2010; 18: 598–603.CrossRef
65.
Achenbach S, Raggi P. Imaging of coronary atherosclerosis by computed tomography. Eur Heart J 2010; 31: 1442-48.PubMedCrossRef
66.
Bax JJ, Schuijff JD, Wall EE van der. Niet-invasieve beeldvorming voor detectie van coronairlijden. Ned Tijdschr Geneeskd 2007; 151: 799–804.PubMed
67.
Bemmel BM van, Maas AHEM, Ottervanger JP. Toegevoegde waarde van de coronaire calciumscore bij de bepaling van cardiovasculair risico. Hartbulletin 2009; 40: 112–16.
68.
Budoff MJ, Hokanson JE, Nasir K, Shaw LJ, Kinney GL, Chow D, et al. Progression of coronary artery calcium predicts all-cause mortality. J Am Coll Cardiol Img 2010; 3: 1229–36.
69.
Litwin SE, Priester TC. Diagnosing coronary artery disease in women. Obstet Gynaecol 2010; 115: 156-69.CrossRef
70.
Ahmadi N, Nabavi V, Hajsadeghi F, Flores F, French WJ, Mao SS, Shavelle D, Ebrahimi R, Budoff M. Mortality incidence of patients with non-obstructive coronary artery disease diagnosed by computed tomography angiography. Am J Cardiol 2011; 107: 10–16.PubMedCrossRef
71.
Jacobs AK. Coronary intervention in 2009. Are women no different than men? Circ Cardiovasc Intervent 2009; 2: 69–78.CrossRef
72.
73.
Baroletti S, Dell’Orfano H. Medication adherence in cardiovascular disease. Circulation 2010; 121: 1455–58.PubMedCrossRef
74.
Oertelt-Prigione S, Regitz-Zagrosek V. Gender Aspects in cardiovascular pharmacology. J Cardiovasc Trans Res 2009; 2: 258–66.CrossRef
75.
Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women, 2011 update. A guideline from the American Heart Association. Circulation 2011; 123: 1243–62.PubMedCrossRef
76.
Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005; 352: 1293–304.PubMedCrossRef
77.
Gulati M, Cooper-DeHoff RM, McClure C, Johnson D, Shaw LJ, Handberg EM, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease. A report from the Women’s Ischemia Syndrome Evaluation Study and the St James Women take Heart Project. Arch Intern Med 2009; 169: 843–50.PubMedCrossRef
Metagegevens
Titel
Genderverschillen bij Coronaire Hartziekten
Auteurs
Dr. Aagela Maas
Prof. Dr. Toine Lagro-Janssen
Copyright
2011
Uitgeverij
Bohn Stafleu van Loghum
Boek
Handboek gynaecardiologie

Print ISBN: 978-90-313-8781-6

Elektronisch ISBN: 978-90-313-8782-3

Copyright: 2011

DOI
https://doi.org/10.1007/978-90-313-8782-3_2